Sunhee Kim
Medical · Fresh Meadows, NYNPI 1073920385
Payments from drug & device makers
Across 120 payments — averaging $30.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$562
- Merck$448
- Johnson & Johnson$241
- Incyte Corporation$222
- Daiichi Sankyo Inc.$218
- Takeda Pharmaceuticals U.S.A., Inc.$167
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,56897%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 11 | $562 |
| Merck | 17 | $448 |
| Johnson & Johnson(2 entities) | 9 | $241 |
| Incyte Corporation | 6 | $222 |
| Daiichi Sankyo Inc. | 8 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $167 |
| Sanofi | 2 | $147 |
| Dova Pharmaceuticals | 1 | $125 |
| Abbott | 1 | $121 |
| Genentech USA, Inc. | 5 | $112 |
| Ipsen Biopharmaceuticals, Inc | 2 | $89 |
| Bayer | 4 | $88 |
| Janssen Scientific Affairs, LLC | 2 | $88 |
| Pharmacosmos Therapeutics Inc. | 4 | $84 |
| Sobi, Inc | 3 | $82 |
| GSK | 3 | $81 |
| Kyowa Kirin, Inc. | 3 | $71 |
| Agios Pharmaceuticals, Inc. | 3 | $70 |
| Pharmaessentia USA Corporation | 4 | $61 |
| Geron Corporation | 2 | $59 |
| Deciphera Pharmaceuticals Inc. | 2 | $52 |
| Tersera Therapeutics LLC | 2 | $51 |
| Karyopharm Therapeutics Inc. | 2 | $48 |
| Stemline Therapeutics Inc. | 2 | $44 |
| Syndax Pharmaceuticals, Inc. | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 1 | $37 |
| Puma Biotechnology, Inc. | 2 | $32 |
| Blueprint Medicines Corporation | 1 | $30 |
| Boehringer Ingelheim | 1 | $26 |
| Genmab U.S., Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $26 |
| Eisai Inc. | 1 | $23 |
| Novocure Inc. | 1 | $21 |
| Coherus Oncology, Inc. | 1 | $19 |
| Beone Medicines USA, Inc. | 1 | $19 |
| Novartis | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,668 in reported general payments places this provider in the 85th percentile of 2,395 medical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $16,604 |
| Exemestane | 14 | $4,186 |
| Acyclovir | 28 | $410 |
| Anastrozole | 11 | $152 |
| LoperamideLoperamide Hcl | 12 | $141 |
Paid to pharmacies, not to this prescriber.
Other medical in Fresh Meadows
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.